SUNY Downstate Medical School, Brooklyn, NY.
Department of Dermatology, Weill Cornell Medicine, New York, NY;
Skinmed. 2020 Dec 1;18(6):367-371. eCollection 2020.
Onychomycosis was first described in the mid-1800's, and early treatment regimens involved applying corrosive substances and nail plate avulsion. It was not until the mid-1900's that more specific antifungal agents were utilized. Initially, only oral drugs were used, with ciclopirox 8% solution later approved in 1999. Presently, terbinafine, itraconazole, and fluconazole (off-label) are used for systemic onychomycosis therapy in the US, and topicals include ciclopirox, efinaconazole and tavaborole. Devices, topicals with new mechanisms of action, and oral medications with potentially better efficacy are now being explored for treatment of onychomycosis.
甲真菌病于 19 世纪中期首次被描述,早期的治疗方案包括应用腐蚀性物质和指甲板剥离。直到 20 世纪中期,才开始使用更具针对性的抗真菌药物。起初,仅使用口服药物,后来于 1999 年批准使用 8%环吡酮胺溶液。目前,特比萘芬、伊曲康唑和氟康唑(超适应证用药)在美国用于系统性甲真菌病的治疗,局部治疗药物包括环吡酮胺、依氟康唑和他泊康唑。目前正在探索用于治疗甲真菌病的设备、具有新作用机制的局部药物和潜在疗效更好的口服药物。